Literature DB >> 1422061

Human hepatitis B vaccine from recombinant yeast. 1984.

W J McAleer, E B Buynak, R Z Maigetter, D E Wampler, W J Miller, M R Hilleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422061

Source DB:  PubMed          Journal:  Biotechnology        ISSN： 0740-7378


× No keyword cloud information.
  5 in total

1.  Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Authors:  Katharina M Uhlig; Stefan Schülke; Vivian A M Scheuplein; Anna H Malczyk; Johannes Reusch; Stefanie Kugelmann; Anke Muth; Vivian Koch; Stefan Hutzler; Bianca S Bodmer; Axel Schambach; Christian J Buchholz; Zoe Waibler; Stephan Scheurer; Michael D Mühlebach
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

2.  One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.

Authors:  Ruikang Liu; Jeffrey L Americo; Catherine A Cotter; Patricia L Earl; Noam Erez; Chen Peng; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

3.  MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease.

Authors:  Ruikang Liu; Jeffrey L Americo; Catherine A Cotter; Patricia L Earl; Noam Erez; Chen Peng; Bernard Moss
Journal:  bioRxiv       Date:  2021-01-01

Review 4.  Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2.

Authors:  Farshad Hemmati; Mohsen Hemmati-Dinarvand; Marziye Karimzade; Daria Rutkowska; Mohammad Hadi Eskandari; Sayyad Khanizadeh; Alireza Afsharifar
Journal:  Biotechnol Lett       Date:  2021-11-27       Impact factor: 2.716

Review 5.  Virus-like particle vaccinology, from bench to bedside.

Authors:  Mona O Mohsen; Martin F Bachmann
Journal:  Cell Mol Immunol       Date:  2022-08-12       Impact factor: 22.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.